Novanta Inc. (NOVT)

Market Cap	4.75B +25.9%
Revenue (ttm)	980.60M +3.3%
Net Income	53.83M -16.0%
EPS	1.47 -16.9%
Shares Out	35.68M
PE Ratio	91.46
Forward PE	37.73
Dividend	n/a
Ex-Dividend Date	n/a

Volume	273,659
Open	133.33
Previous Close	133.19
Day's Range	131.80 - 137.13
52-Week Range	98.27 - 149.95
Beta	1.65
Analysts	Buy
Price Target	144.00 (+8.09%)
Earnings Date	May 11, 2026

About NOVT

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment s...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• Founded: 1968
• Employees: 3,000
• Stock Exchange: NASDAQ
• Ticker Symbol: NOVT
• Website: https://www.novanta.com

Financial Performance

In 2025, Novanta's revenue was $980.60 million, an increase of 3.30% compared to the previous year's $949.25 million. Earnings were $53.83 million, a decrease of -16.01%.

Analyst Summary

According to one analyst, the rating for NOVT stock is "Buy" and the 12-month stock price target is $144.0.

Price Target

$144.0

(8.09% upside)

Analyst Consensus: Buy